Tan P - Search Results

1

How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?

Tiong IS, Wall M, Bajel A, Kalro A, Fleming S, Roberts AW, Thiagarajah N, Chua CC, Latimer M, Yeung D, Marlton P, Johnston A, Enjeti A, Fong CY, Cull G, Larsen S, Kennedy G, Schwarer A, Kipp D, Ramanathan S, Verner E, Tiley C, Morris E, Hahn U, Moore J, Taper J, Purtill D, Warburton P, Stevenson W, Murphy N, Tan P, Beligaswatte A, Mutsando H, Hertzberg M, Shortt J, Szabo F, Dunne K, Wei AH; Australasian Leukaemia and Lymphoma Group (ALLG). Tiong IS, et al. Among authors: tan p. Blood Cancer J. 2024 Mar 26;14(1):54. doi: 10.1038/s41408-024-00996-x. Blood Cancer J. 2024. PMID: 38531863 Free PMC article.

2

The epigenomics revolution in myelodysplasia: a clinico-pathological perspective.

Tan PT, Wei AH. Tan PT, et al. Pathology. 2011 Oct;43(6):536-46. doi: 10.1097/PAT.0b013e32834a4061. Pathology. 2011. PMID: 21881538 Review.

3

Limitations of targeted therapy with sorafenib in elderly high-risk myelodysplastic syndrome and acute myeloid leukemia.

Wei A, Tan P. Wei A, et al. Among authors: tan p. Leuk Lymphoma. 2013 Apr;54(4):675-6. doi: 10.3109/10428194.2012.731604. Epub 2012 Oct 4. Leuk Lymphoma. 2013. PMID: 22988956 No abstract available.

4

Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients.

Govindaraj C, Tan P, Walker P, Wei A, Spencer A, Plebanski M. Govindaraj C, et al. Among authors: tan p. Clin Cancer Res. 2014 Feb 1;20(3):724-35. doi: 10.1158/1078-0432.CCR-13-1576. Epub 2013 Dec 2. Clin Cancer Res. 2014. PMID: 24297862 Clinical Trial.

5

Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia.

Wei A, Tan P, Perruzza S, Govindaraj C, Fleming S, McManus J, Avery S, Patil S, Stevenson W, Plebanski M, Spencer A. Wei A, et al. Among authors: tan p. Br J Haematol. 2015 Apr;169(2):199-210. doi: 10.1111/bjh.13281. Epub 2015 Feb 2. Br J Haematol. 2015. PMID: 25643589 Free article. Clinical Trial.

6

Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia.

Tiong IS, Tan P, McManus J, Cummings N, Sadawarte S, Catalano J, Hills R, Wei A. Tiong IS, et al. Among authors: tan p. Leuk Lymphoma. 2018 Feb;59(2):493-496. doi: 10.1080/10428194.2017.1334122. Epub 2017 Jun 8. Leuk Lymphoma. 2018. PMID: 28592158 Clinical Trial. No abstract available.

7

The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study.

Tan P, Tiong IS, Fleming S, Pomilio G, Cummings N, Droogleever M, McManus J, Schwarer A, Catalano J, Patil S, Avery S, Spencer A, Wei A. Tan P, et al. Oncotarget. 2016 Nov 29;8(32):52269-52280. doi: 10.18632/oncotarget.13699. eCollection 2017 Aug 8. Oncotarget. 2016. PMID: 28881728 Free PMC article.

8

Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation.

Iland HJ, Russell N, Dillon R, Schuh AC, Tedjaseputra A, Wei A, Khwaja A, Knapper S, Lane SW, Reynolds J, McMullin MF, Martin A, Tan P, Taussig DC, Wong A, Taper J, Fraga C, Kelly R, Tawana K, Mehta P, Mina A, Altman JK, Mølle I, Tauro S, Tholouli E. Iland HJ, et al. Among authors: tan p. Blood Adv. 2023 Jun 13;7(11):2580-2585. doi: 10.1182/bloodadvances.2022007126. Blood Adv. 2023. PMID: 36075018 Free PMC article. No abstract available.

9

Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients.

Govindaraj C, Madondo M, Kong YY, Tan P, Wei A, Plebanski M. Govindaraj C, et al. Among authors: tan p. Am J Hematol. 2014 Aug;89(8):795-802. doi: 10.1002/ajh.23746. Epub 2014 May 16. Am J Hematol. 2014. PMID: 24757092 Free article. Clinical Trial.

10

Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome.

Tan P, Wei A, Mithraprabhu S, Cummings N, Liu HB, Perugini M, Reed K, Avery S, Patil S, Walker P, Mollee P, Grigg A, D'Andrea R, Dear A, Spencer A. Tan P, et al. Blood Cancer J. 2014 Jan 10;4(1):e170. doi: 10.1038/bcj.2013.68. Blood Cancer J. 2014. PMID: 24413064 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,931 results

Search Page